The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells

Apoptosis

Volumn 12, Issue 3, 2007, Pages 475-487

  Hung, Hui Chih ^a   Lin, Chien Yu ^b   Liao, Ya Fan ^a   Hsu, Pei Chen ^a,c   Tsay, Gregory J ^d   Liu, Guang Yaw ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c Da Chien General Hospital   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Bax; Bcl xL; Cytochrome c; PADIs; SNP PADI4

Indexed keywords

CYTOCHROME C; IONOMYCIN; PEPTIDYLARGININE DEIMINASE IV; PROTEIN ARGININE DEIMINASE; PROTEIN BAX; PROTEIN BCL XL; TETRACYCLINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVITY; ENZYME RELEASE; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MITOCHONDRION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CASPASES; CELL SURVIVAL; ENZYME ACTIVATION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYDROLASES; JURKAT CELLS; MUTAGENESIS, SITE-DIRECTED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33847297986     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0005-0     Document Type: Article

References (60)

1. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25:1106-1118
2. Suzuki A, Yamada R, Chang X et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395-402
3. Tommasi C, Petit-Teixeira E, Cournu-Rebeix I et al. (2006) PADI4 gene in multiple sclerosis: a family-based association study. J Neuroimmunol 177:142-145
4. Ishida-Yamamoto A, Senshu T, Takahashi H, Akiyama K, Nomura K, Iizuka H (2000) Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J Invest Dermatol 114:701-705
5. Maruyama N, Ishigami A (2005) Pathophysiological significances of citrullinated proteins in geriatric diseases. Nippon Ronen Igakkai Zasshi 42:519-522
6. Ishigami A, Ohsawa T, Hiratsuka M et al. (2005) Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 80:120-128
7. Guerrin M, Ishigami A, Mechin MC et al. (2003) cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J 370:167-174
8. Ishigami A, Ohsawa T, Asaga H, Akiyama K, Kuramoto M, Maruyama N (2002) Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch Biochem Biophys 407:25-31
9. Kanno T, Kawada A, Yamanouchi J et al. (2000) Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. J Invest Dermatol 115:813-823
10. Nakashima K, Hagiwara T, Ishigami A et al. (1999) Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J Biol Chem 274:27786-27792
11. Chavanas S, Mechin MC, Takahara H et al. (2004) Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene 330:19-27
12. Liu GY, Liao YF, Chang WH et al. (2006) Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells. Apoptosis 11:183-196
13. Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, vanVenrooij WJ (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 350:17-34
14. Chang X, Yamada R, Suzuki A et al. (2005) Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44:40-50
15. Senshu T, Akiyama K, Ishigami A, Nomura K (1999) Studies on specificity of peptidylarginine deiminase reactions using an immunochemical probe that recognizes an enzymatically deiminated partial sequence of mouse keratin K1. J Dermatol Sci 21:113-126
16. Ishida-Yamamoto A, Senshu T, Eady RA et al. (2002) Sequential reorganization of cornified cell keratin filaments involving filaggrin-mediated compaction and keratin 1 deimination. J Invest Dermatol 118:282-287
17. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM (1996) Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271:30709-30716
18. Vossenaar ER, Radstake TR, Van Der Heijden A et al. (2004) Expression and activity of citrullinating peptidylarginine deiminase enzymes inmonocytes andmacrophages. Ann Rheum Dis 63:373-381
19. Moscarello MA, Wood DD, Ackerley C, Boulias C (1994) Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94:146-154
20. Wang Y, Wysocka J, Sayegh J et al. (2004) Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306:279-283
21. Cuthbert GL, Daujat S, Snowden A et al. (2004) Histone deimination antagonizes arginine methylation. Cell 118:545-553
22. Vossenaar ER, Nijenhuis S, Helsen M M et al. (2003) Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 48:2489-2500
23. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha-and beta-chains of fibrin. J Immunol 166:4177-4184
24. Suzuki A, Yamada R, Ohtake-Yamanaka M, Okazaki Y, Sawada T, Yamamoto K (2005) Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 333:418-426
25. Kinloch A, Tatzer V, Wait R et al. (2005) Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 7:1421-1429
26. Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K (2005) The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 44:293-298
27. Okazaki Y, Suzuki A, Sawada T et al. (2006) Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis. Biochem Biophys Res Commun 341:94-100
28. Wood DD, Bilbao JM, O'Connors P, Moscarello MA (1996) Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 40:18-24
29. Wright PW, Bolling LC, Calvert ME et al. (2003) ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol 256:73-88
30. Asaga H, Yamada M, Senshu T (1998) Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 243:641-646
31. Mizoguchi M, Manabe M, Kawamura Y et al. (1998) Deimination of 70-kD nuclear protein during epidermal apoptotic events in vitro. J Histochem Cytochem 46:1303-1309
32. Senshu T, Akiyama K, Nagata S, Watanabe K, Hikichi K (1989) Peptidylarginine deiminase in rat pituitary: sex difference, estrous cycle-related changes, and estrogen dependence. Endocrinology 124:2666-2670
33. Okuda M (2002) The role of nucleophosmin in centrosome duplication. Oncogene 21:6170-6174
34. Hingorani K, Szebeni A, Olson MO (2000) Mapping the functional domains of nucleolar protein B23. J Biol Chem 275:24451-24457
35. Takemura M, Ohoka F, Perpelescu M et al. (2002) Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23. Exp Cell Res 276:233-241
36. Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M (2002) Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 290:979-983
37. Hagiwara T, Hidaka Y, Yamada M (2005) Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. Biochemistry 44:5827-5834
38. Liu H, Pope RM (2003) The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol 3:317-322
39. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC (2006) A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54:90-96
40. Liu GY, Hung YC, Hsu PC et al. (2005) Ornithine decarboxylase prevents tumor necrosis factor alpha-induced apoptosis by decreasing intracellular reactive oxygen species. Apoptosis 10:569-581
41. Huang CC, Hsu PC, Hung YC et al. (2005) Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production. Apoptosis 10:895-907
42. Liao YF, Hsieh HC, Liu GY, Hung HC (2005) A continuous spectrophotometric assay method for peptidylarginine deiminase type 4 activity. Anal Biochem 347:176-181
43. Boyde TR, Rahmatullah M (1980) Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem 107:424-431
44. Cheng WH, Quimby FW, Lei XG (2003) Impacts of glutathione peroxidase-1 knockout on the protection by injected selenium against the pro-oxidant-induced liver aponecrosis and signaling in selenium-deficient mice. Free Radic Biol Med 34:918-927
45. Jamison JM, Gilloteaux J, Taper HS, Calderon PB, Summers JL (2002) Autoschizis: a novel cell death. Biochem Pharmacol 63:1773-1783
46. Skulachev VP (2006) Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 11:473-485
47. Grossmann J (2002) Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 7:247-260
48. Lum JJ, Bauer DE, Kong M et al. (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120:237-248
49. Levine B (2005) Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 120:159-162
50. Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M (2004) Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 11:777-783
51. Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C (1989). Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem 264:18119-18127
52. Nakashima K, Hagiwara T, Yamada M (2002) Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 277:49562-49568
53. Appella E, Anderson CW (2000) Signaling to p53: breaking the posttranslational modification code. Pathol Biol (Paris) 48:227-245
54. Munoz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J, Leon J (2005) p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem 280:18120-18129
55. Norbury CJ, Zhivotovsky B (2004) DNA damage-induced apoptosis. Oncogene 23:2797-2808
56. Itoh K, Hase H, Kojima H, Saotome K, Nishioka K, Kobata T (2004) Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Rheumatology (Oxford) 43:277-285
57. Schuler M, Green DR (2005) Transcription, apoptosis and p53: catch-22. Trends Genet 21:182-187
58. Chipuk JE, Kuwana T, Bouchier-Hayes L et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010-1014
59. Salmon M, Scheel-Toellner D, Huissoon AP et al. (1997) Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 99:439-446
60. Denny MF, Chandaroy P, Killen PD et al. (2006) Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol 176:2095-2104